International Conferences

Recommended Conferences for Sleep Therapy

Sleep Therapy

---

Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums so far in the field.

As per survey conducted by the National Commission on Sleep Disorders Research, approximately +38,000 deaths occur on an annual basis that relate to cardiovascular problems that are connected to sleep apnea directly or indirectly. These patients face problems like high blood pressure and hypertension, stroke and others. As per estimated more than six million American residents suffer from sleep apnea that is moderate to severe. Many peoples suffer with Sleep Disorders i.e., around +500,000 individuals but they don’t realized it.There are 80 journals, 100 Conferences, 31 workshops are presently dedicated exclusively to Sleep Disorder and 72047+ articles are being publishing on the current trends in embodiment of Sleep Disorders like Sleep apnea treatment and research.

OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker. 

Importance and Scope:

Sleep therapy is a medical specialty or subspecialty devoted to the diagnosis and therapy of sleep disturbances and related disorders. Scientist have provided increasing knowledge through research, and answered many questions about sleep-wake functioning related questions. Sleep therapy/Disorders are rapidly evolving field and has become a recognized medical subspecialty in some countries in all the continents.

The cases of Sleep Disorders are there because, people either do not report the condition or do not know they have sleep apnea with them. There were reports in Max (2004) articles, Sleep Disorder or Somnipathys medical disorder of the sleep patterns of a person. Sleep disorders are serious enough to interfere with normal physics and mental conditions, emotional functioning. Scientist use polysomnography to test sleep disorders.

Scientists have recently reported that curing insomnia in people with depression could double their chance of a full recovery. It has been seen that treatment of insomnia generally includes talk therapy rather than drugs. These talk therapies are the first to emerge from a series of closely watched studies of sleep and depression to be released in the coming year.

According to one recent study which has been done by Ryerson University in Toronto, it has been found that 87 percent of patients who resolved their insomnia in four biweekly talk therapy sessions also saw their depression symptoms dissolve after eight weeks of treatment. With a previous pilot study of insomnia treatment at Stanford those numbers are in line. Researchers and medical related people are very well aware that sleep problems are intertwined with mood disorders. But only recently have they begun to investigate the effects of treating both at the same time.

It should be noted that full-blown insomnia is more serious than the sleep problems most people occasionally have. People must have endured at least a month of chronic sleep loss that has caused problems at work to qualify for a diagnosis. It has been shown by numerous studies that developing insomnia doubles a person’s risk of later becoming depressed.

It has been pointed by several people through interviews that the National Institute of Mental Health had sharply curtailed funding for work in sleep treatment. In an interview the acting chief of the agency’s behavioral and integrative neuroscience research branch claimed that in 2009 the funding strategy changed for sleep projects. It has been seen that the agency is now focusing on how sleep affects the functioning of neural circuits in an effort to illuminate the biology of sleep’s impact on behavior. However chief has also added that the agency continued to fund clinical work like the depression trials.

In order to explore new strategies for controlling sleep and other related problems ConferenceSeries is organizing Stress Management Summit at Philadelphia during July 13-15, 2015.

ConferenceSeries International is an amalgamation of Open Access publications and worldwide international scientific conferences and events. In all aspects of Management, Science and Engineering and Technology, ConferenceSeries publishes 350 online open access scholarly journals . OMICS has 21 days rapid review process involving 30,000 editorial team members with 3.5 Million readers. OMICS ‘Open Access’ has been instrumental in taking the knowledge on science & technology to the doorsteps of ordinary men and women. Research scholars, students, libraries, educational institutions, research centres and the industries are main stakeholders that benefit greatly from this knowledge dissemination. ConferenceSeries also organizes 100 International conferences annually across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, International workshops, International symposia and exhibitions. 

List of Best International Conferences

• 5^th Neurology Congress March 14-16, 2016 London, UK
• 2^nd Parkinson’s Disease and Movement Disorders Conference November 28-30, 2016 Chicago, USA
• 2^nd Brain Disorders Conference October 27-29, 2016 Chicago, USA
• Dual diagnosis Conference July 21-22, 2016 Chicago, USA
• Neuro Rehabilitation Conference July 21-22, 2016 Brisbane, Australia
• 6^th  Neurological conference  May 19-21, 2016 San Antonio, USA
• 4^th Vascular Dementia Conference June 30-July 2, 2016 Valencia, Spain
• 2^nd Epilepsy Conference October 24-26, 2016 Rome, Italy
• 2^nd Depression, Anxiety and Stress Management Meeting November 3-4, 2016 Valencia, Spain
• 5^th Alzheimer’s Disease and Dementia Conference September 29-Oct 1, 2016 London, UK
• 2^nd Neurological Disorders and Stroke Conference April 28-30, 2016 Dubai, UAE
• Anxiety and Depression Conference 2016
• Treating Depression 2016
• 14^th Annual Depression on College Campuses Conference

List of Related Societies

• American Psychiatric Association
• World Psychiatric Association
• Anxiety and Depression Association of America
• European Depression Association
• Depression and Bipolar Support Alliance
• American Sleep Association
• Australasian Sleep Association
• National Sleep Foundation, Arlington, VA
• American Academy of Sleep Medicine
• The British Sleep Society (BSS)
• American Sleep Apnea Association
• British Snoring & Sleep Apnoea Association
• The Sleep Research Society
• The Southern Sleep Society

List of Related Companies

·         Pfizer

·         Roch

·         Novartis

·         Merck

·         GlaxoSmithKline

The major role played in the antidepressant market are Eli Lilly, Wyeth, Forest Laboratories, Pfizer, GlaxoSmithKline and Schering-Plough. Effexor holds the largest market share in the antidepressants market, at 36% ($3.93 billion), while Cymbalta grew the fastest, with sales jumping by 29% from $2.1 billion in 2007 to $2.7 billion in 2008.

This page will be updated regularly.

This page was last updated on April 19, 2024